Detected Compounds
4
Multi-class psychiatric / sedative panel
CNS Depression Risk Index
High (Multi-Sedative Potentiation)
Cumulative GABA + H1 receptor inhibition
Metabolic Clearance Bottleneck
CYP2D6 & CYP2C19 Competition Detected
Enzymatic substrate saturation risk
Active CYP Pathways
4 Pathways
CYP3A4, CYP2C19, CYP2D6, UGT1A4
Active Forensic Analytes
4 ActivePharmacokinetic Serum Clearance Timeline (0–120h)
First-Order Elimination Kinetics ($C_t = C_0 \cdot e^{-kt}$)Hepatic CYP450 Enzymatic Load & Competition
Hepatic Clearance SaturationStructured Forensic Toxicology Findings Table
Clinical Reference Grade| Compound Name | Class / Sub-Type | Dose Sim (mg) | Elimination $T_{1/2}$ | Primary CYP / UGT Isozymes | CNS Score | Pharmacodynamic Interaction Risk |
|---|
Forensic Analysis Verification Dossier
Report Title
Forensic Multi-Analyte Panel Screen
Total Analytes Detected
4
CNS Depression Risk Classification
High (Multi-Sedative Potentiation)
Metabolic Clearance Bottleneck
CYP2D6 & CYP2C19 Competition Detected
Co-Engaged CYP Pathways
CYP3A4, CYP2C19, CYP2D6